Glucocorticoid treatment in SLE is associated with infections, comorbidities and mortality-a national cohort study.

Frodlund, Martina; Jönsen, Andreas; Remkus, Lauren; Telg, Gunilla; Söderdahl, Fabian; Leonard, Dag

Frodlund, Martina; Jönsen, Andreas; Remkus, Lauren; Telg, Gunilla; Söderdahl, Fabian; Leonard, Dag.

Affiliation

Frodlund M; Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection/Rheumatology, Linköping University, Linköping, Sweden.
Jönsen A; Department of Clinical Sciences Lund, Rheumatology, Lund University, Lund, Sweden.
Remkus L; AstraZeneca A/S, Copenhagen, Denmark.
Telg G; AstraZeneca Nordics, Sodertalje, Sweden.
Söderdahl F; Statisticon AB, Uppsala, Sweden.
Leonard D; Rheumatology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Rheumatology (Oxford) ; 63(4): 1104-1112, 2024 Apr 02.

Article in En | MEDLINE | ID: mdl-37439705

Subject(s)

Glucocorticoids; Lupus Erythematosus, Systemic; Humans; Adolescent; Cohort Studies; Glucocorticoids/therapeutic use; Comorbidity; Risk Factors; Lupus Erythematosus, Systemic/complications; Lupus Erythematosus, Systemic/drug therapy; Lupus Erythematosus, Systemic/epidemiology

Key words

SLE; comorbidities; corticosteroids; immunosuppressants; infections; malignancies; mortality; organ damage; prednisolone; survival

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glucocorticoids / Lupus Erythematosus, Systemic Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Humans Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2024 Type: Article Affiliation country: Sweden

Fulltext

XML

PubMed Links

Search on Google